Agenda item

Presentation by Head of Commissioning and Strategy, NHS Tees Valley Clinical Commissioning Group

The Head of Commissioning and Strategy, NHS Tees Valley Clinical Commissioning Group gave a presentation updating Members on the COVID-19 Vaccination Programme.

It was reported that the NHSE vaccination target was 90 per cent for first doses; that the data up to and including 22 August showed that Darlington had achieved 85.19 per cent for first doses, which was above the North East and North Cumbria rate; and had achieved 74.28 per cent for second doses, with numbers still increasing.

Details were provided of the vaccination uptake for the JCVI cohorts and ethnic groups, with further work required to encourage the younger population and white British population to receive the vaccine.

The vaccination sites in Darlington were outlined; a clinic had been scheduled for 3 September for high risk 12 – 15 year olds; and Phase 3 rollout was due to commence on 6 September, with flu and covid vaccinations being given at the same time, where appropriate.

Discussion ensued in respect of booster vaccinations for vulnerable groups; whilst it was anticipated that the rollout would commence in September, no formal decision had been made but was expected in the next few weeks.

The success of the pop-up vaccination clinic at Darlington Pride was highlighted and members queried plans for pop-up clinics at upcoming events in Darlington.

RESOLVED – That the Head of Commissioning and Strategy, NHS Tees Valley Clinical Commissioning Group be thanked for her informative and interesting presentation.